This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

COVIPEDIA
Loading...

Rezaei, Nima


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020 Apr 6:1-6. doi: 10.1080/1744666X.2020.1750954. [Epub ahead of print] PubMed PMID: 32237901; PubMed Central PMCID: PMC7157951.
3.792
69
2
Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being. J Clin Virol. 2020 May;126:104345. doi: 10.1016/j.jcv.2020.104345. Epub 2020 Apr 4. PubMed PMID: 32278298; PubMed Central PMCID: PMC7129277.
2.777
66
3
Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020 May 29;508:254-266. doi: 10.1016/j.cca.2020.05.044. [Epub ahead of print] Review. PubMed PMID: 32474009; PubMed Central PMCID: PMC7256510.
2.615
52
2
Saghazadeh A, Rezaei N. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol. 2020 May 8;84:106560. doi: 10.1016/j.intimp.2020.106560. [Epub ahead of print] Review. PubMed PMID: 32413736; PubMed Central PMCID: PMC7205724.
3.943
48
1
Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: Friend or foe? Life Sci. 2020 Jun 2:117900. doi: 10.1016/j.lfs.2020.117900. [Epub ahead of print] Review. PubMed PMID: 32502542; PubMed Central PMCID: PMC7266583.
3.647
34
2
Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic Opportunities. Cell Biol Int. 2020 May 27. doi: 10.1002/cbin.11403. [Epub ahead of print] Review. PubMed PMID: 32458561.
2.571
31
3
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med. 2020 May 19;18(1):205. doi: 10.1186/s12967-020-02364-2. Review. PubMed PMID: 32430070.
4.098
21
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N. All together to Fight Novel Coronavirus Disease (COVID-19). Am J Trop Med Hyg. 2020 Apr 22. doi: 10.4269/ajtmh.20-0281. [Epub ahead of print] PubMed PMID: 32323644.
2.126
20
2
Jahanshahlu L, Rezaei N. Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother. 2020 Jun 4;129:110337. doi: 10.1016/j.biopha.2020.110337. [Epub ahead of print] Review. PubMed PMID: 32534226; PubMed Central PMCID: PMC7269943.
4.545
18
1
Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26123. [Epub ahead of print] Review. PubMed PMID: 32492197.
2.021
17
4
Yousefzadegan S, Rezaei N. Case Report: Death Due to Novel Coronavirus Disease (COVID-19) in Three Brothers. Am J Trop Med Hyg. 2020 Apr 10. doi: 10.4269/ajtmh.20-0240. [Epub ahead of print] PubMed PMID: 32277694.
2.126
16
2
Hanaei S, Rezaei N. COVID-19: Developing from an Outbreak to A Pandemic. Arch Med Res. 2020 May 13. doi: 10.1016/j.arcmed.2020.04.021. [Epub ahead of print] PubMed PMID: 32405122; PubMed Central PMCID: PMC7219390.
2.093
16
3
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 2020 May 28. pii: /j/revneuro.ahead-of-print/revneuro-2020-0026/revneuro-2020-0026.xml. doi: 10.1515/revneuro-2020-0026. [Epub ahead of print] Review. PubMed PMID: 32463395.
3.358
13
2
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N. Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infect Control Hosp Epidemiol. 2020 Apr 22:1-2. doi: 10.1017/ice.2020.162. [Epub ahead of print] PubMed PMID: 32319878; PubMed Central PMCID: PMC7231663.
2.938
13
2
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020 Aug 1:118185. doi: 10.1016/j.lfs.2020.118185. [Epub ahead of print] Review. PubMed PMID: 32750438.
3.647
12
2
Nasab MG, Saghazadeh A, Rezaei N. SARS-CoV-2-A Tough Opponent for the Immune System. Arch Med Res. 2020 May 30. pii: S0188-4409(20)30749-9. doi: 10.1016/j.arcmed.2020.05.020. [Epub ahead of print] PubMed PMID: 32532524; PubMed Central PMCID: PMC7260490.
2.093
11
3
Darbeheshti F, Rezaei N. Genetic predisposition models to COVID-19 infection. Med Hypotheses. 2020 May 6;142:109818. doi: 10.1016/j.mehy.2020.109818. [Epub ahead of print] PubMed PMID: 32416414; PubMed Central PMCID: PMC7202332.
1.375
11
4
Bahrami A, Vafapour M, Moazzami B, Rezaei N. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran. J Paediatr Child Health. 2020 Jul 8. doi: 10.1111/jpc.15048. [Epub ahead of print] PubMed PMID: 32640066.
1.71
10
3
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N. COVID-19: A Chimera of Two Pandemics. Disaster Med Public Health Prep. 2020 Jun 25:1-3. doi: 10.1017/dmp.2020.223. [Epub ahead of print] PubMed PMID: 32580806.
0.977
10
4
Jabbari P, Taraghikhah N, Jabbari F, Ebrahimi S, Rezaei N. Adherence of the General Public to Self-protection Guidelines During the COVID-19 Pandemic. Disaster Med Public Health Prep. 2020 Nov 18:1-12. doi: 10.1017/dmp.2020.445. [Epub ahead of print] PubMed PMID: 33203487.
0.977
10
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises. Stem Cell Rev Rep. 2020 Jun 20. doi: 10.1007/s12015-020-09994-5. [Epub ahead of print] Review. PubMed PMID: 32564256; PubMed Central PMCID: PMC7305935.
2.484
9
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux AF, Janne P, Gourdin M, Delanghe JR, Ochs HD, Talmadge JE, Garg M, Hamblin MR, Rezaei N. Quantity does not equal quality: Scientific principles cannot be sacrificed. Int Immunopharmacol. 2020 Sep;86:106711. doi: 10.1016/j.intimp.2020.106711. Epub 2020 Jun 22. PubMed PMID: 32585609; PubMed Central PMCID: PMC7307981.
3.943
8
Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020 Apr 16:1. doi: 10.1017/ice.2020.139. [Epub ahead of print] PubMed PMID: 32297847; PubMed Central PMCID: PMC7180324.
2.938
8
2
Seyedpour S, Khodaei B, Loghman AH, Seyedpour N, Kisomi MF, Balibegloo M, Nezamabadi SS, Gholami B, Saghazadeh A, Rezaei N. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. J Cell Physiol. 2020 Sep 9. doi: 10.1002/jcp.30032. [Epub ahead of print] Review. PubMed PMID: 32901936.
5.546
7
1
Mojtabavi H, Saghazadeh A, Rezaei N. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020 Jun 1;31(2):44-49. doi: 10.1684/ecn.2020.0448. PubMed PMID: 32933891.
7
Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M, Aljabali AAA, Lal A, Azad GK, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Questions concerning the proximal origin of SARS-CoV-2. J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26478. [Epub ahead of print] PubMed PMID: 32880995.
2.021
6
4
Jahanshahlu L, Rezaei N. Central Nervous System Involvement in COVID-19. Arch Med Res. 2020 May 22. pii: S0188-4409(20)30797-9. doi: 10.1016/j.arcmed.2020.05.016. [Epub ahead of print] PubMed PMID: 32471704; PubMed Central PMCID: PMC7242947.
2.093
5
3
Lotfi M, Rezaei N. CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother. 2020 Nov;131:110738. doi: 10.1016/j.biopha.2020.110738. Epub 2020 Sep 17. Review. PubMed PMID: 33152914.
4.545
4
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol. 2020 Jul 31:173455. doi: 10.1016/j.ejphar.2020.173455. [Epub ahead of print] PubMed PMID: 32745604.
3.263
4
2
Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251. [Epub ahead of print] PubMed PMID: 32619062.
2.021
4
4
Babaha F, Rezaei N. Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? Am J Med Sci. 2020 Jul 29. pii: S0002-9629(20)30339-6. doi: 10.1016/j.amjms.2020.07.027. [Epub ahead of print] PubMed PMID: 32773108.
1.911
4
2
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N. Microfluidic devices for detection of RNA viruses. Rev Med Virol. 2020 Aug 26:e2154. doi: 10.1002/rmv.2154. [Epub ahead of print] Review. PubMed PMID: 32844526.
4.221
3
1
Yazdanpanah N, Saghazadeh A, Rezaei N. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. 2020 Aug 10. pii: /j/revneuro.ahead-of-print/revneuro-2020-0039/revneuro-2020-0039.xml. doi: 10.1515/revneuro-2020-0039. [Epub ahead of print] Review. PubMed PMID: 32776905.
3.358
3
2
Pashaei M, Rezaei N. Immunotherapy for SARS-CoV-2: Potential Opportunities. Expert Opin Biol Ther. 2020 Aug 7. doi: 10.1080/14712598.2020.1807933. [Epub ahead of print] PubMed PMID: 32762581.
3.224
3
2
Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, Moazzen N, Nabavi M, Arshi S, Fallahpour M, Bemanian MH, Shokri S, Momen T, Sadeghi-Shabestari M, Molatefi R, Shirkani A, Vosughimotlagh A, Safarirad M, Sharifzadeh M, Pashangzadeh S, Salami F, Shirmast P, Rezaei A, Moeini Shad T, Mohraz M, Rezaei N, Hammarström L, Yazdani R, Aghamohamamdi A. Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency. J Clin Immunol. 2020 Dec 1. doi: 10.1007/s10875-020-00928-x. [Epub ahead of print] PubMed PMID: 33263173.
6.78
2
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review. Bioorg Chem. 2020 Nov 19:104490. doi: 10.1016/j.bioorg.2020.104490. [Epub ahead of print] Review. PubMed PMID: 33261845.
4.831
2
Seyran M, Takayama K, Uversky VN, Lundstrom K, Palù G, Sherchan SP, Attrish D, Rezaei N, Aljabali AAA, Ghosh S, Pizzol D, Chauhan G, Adadi P, Mohamed Abd El-Aziz T, Soares AG, Kandimalla R, Tambuwala M, Sarif Hassan S, Kumar Azad G, Pal Choudhury P, Baetas-da-Cruz W, Serrano-Aroca Á, Brufsky AM, Uhal BD. The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2(†). FEBS J. 2020 Dec 2. doi: 10.1111/febs.15651. [Epub ahead of print] PubMed PMID: 33264497.
4.392
2
Rokni M, Hamblin MR, Rezaei N. Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother. 2020 Aug 25:1-3. doi: 10.1080/21645515.2020.1799669. [Epub ahead of print] PubMed PMID: 32841579.
2.619
2
2
Shojaeefar E, Malih N, Rezaei N. The Possible Double-Edged Sword Effects of Vitamin D on COVID-19: A Hypothesis. Cell Biol Int. 2020 Sep 29. doi: 10.1002/cbin.11469. [Epub ahead of print] PubMed PMID: 32990980.
2.571
1
3
Goudarzi S, Dehghani Firouzabadi F, Dehghani Firouzabadi M, Rezaei N. Cutaneous Lesions and COVID-19: Cystic Painful Lesion in a Case with Positive SARS-CoV-2. Dermatol Ther. 2020 Sep 3:e14266. doi: 10.1111/dth.14266. [Epub ahead of print] PubMed PMID: 32882081.
2.327
1
2
Vakhshoori M, Heidarpour M, Shafie D, Taheri M, Rezaei N, Sarrafzadegan N. Acute Cardiac Injury in COVID-19: A Systematic Review and Meta-analysis. Arch Iran Med. 2020 Nov 1;23(11):801-812. doi: 10.34172/aim.2020.107. PubMed PMID: 33220700.
0.996
1
Pezeshki PS, Rezaei N. Immune Checkpoint Inhibition in COVID-19: Risks and Benefits. Expert Opin Biol Ther. 2021 Feb 5. doi: 10.1080/14712598.2021.1887131. [Epub ahead of print] PubMed PMID: 33543652.
3.224
0
Tantuoyir MM, Rezaei N. Serological Tests for COVID-19: Potential Opportunities. Cell Biol Int. 2020 Dec 2. doi: 10.1002/cbin.11516. [Epub ahead of print] Review. PubMed PMID: 33289157.
2.571
0
Khosroshahi LM, Rezaei N. Dysregulation of the Immune Response in COVID-19. Cell Biol Int. 2020 Dec 2. doi: 10.1002/cbin.11517. [Epub ahead of print] Review. PubMed PMID: 33289192.
2.571
0
Jabalameli N, Rajabi F, Firooz A, Rezaei N. The Overlap between Genetic Susceptibility to COVID-19 and Skin Diseases. Immunol Invest. 2021 Jan 26:1-8. doi: 10.1080/08820139.2021.1876086. [Epub ahead of print] PubMed PMID: 33494631.
2.511
0
Khanmohammadi S, Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19. J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26826. [Epub ahead of print] Review. PubMed PMID: 33506952.
2.021
0
Aleebrahim-Dehkordi E, Soveyzi F, Deravi N, Rabbani Z, Saghazadeh A, Rezaei N. Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children. J Pediatr Nurs. 2020 Oct 22;56:70-79. doi: 10.1016/j.pedn.2020.10.020. [Epub ahead of print] Review. PubMed PMID: 33186866.
1.495
0
Jabbari P, Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? Disaster Med Public Health Prep. 2020 Jul 27:1-3. doi: 10.1017/dmp.2020.274. [Epub ahead of print] PubMed PMID: 32713383.
0.977
0
4
Jenab Y, Rezaei N, Hedayat B, Naderian M, Shirani S, Hosseini K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID-19. Clin Case Rep. 2020 Jul 22. doi: 10.1002/ccr3.3112. [Epub ahead of print] PubMed PMID: 32837723; PubMed Central PMCID: PMC7404759.
0
Ahanchian H, Moazzen N, Sezavar M, Khalighi N, Khoshkhui M, Aelami MH, Motevalli Haghi NS, Rezaei N. COVID-19 in a child with primary antibody deficiency. Clin Case Rep. 2020 Dec 8;9(2):755-758. doi: 10.1002/ccr3.3643. eCollection 2021 Feb. PubMed PMID: 33598240; PubMed Central PMCID: PMC7869323.
0
Hassan SS, Ghosh S, Attrish D, Choudhury PP, Aljabali AAA, Uhal BD, Lundstrom K, Rezaei N, Uversky VN, Seyran M, Pizzol D, Adadi P, Soares A, El-Aziz TMA, Kandimalla R, Tambuwala MM, Azad GK, Sherchan SP, Baetas-da-Cruz W, Takayama K, Serrano-Aroca Á, Chauhan G, Palu G, Brufsky AM. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features. Molecules. 2020 Dec 13;25(24). pii: E5906. doi: 10.3390/molecules25245906. PubMed PMID: 33322198.
0
Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Rep. 2020 Nov 25. doi: 10.1002/ccr3.3557. [Epub ahead of print] PubMed PMID: 33362925; PubMed Central PMCID: PMC7753325.
0
Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw. 2020 Sep 1;31(3):81-93. doi: 10.1684/ecn.2020.0451. PubMed PMID: 33361013.
0
Lundstrom K, Seyran M, Pizzol D, Adadi P, Mohamed Abd El-Aziz T, Hassan SS, Soares A, Kandimalla R, Tambuwala MM, Aljabali AAA, Kumar Azad G, Pal Choudhury P, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Viewpoint: Origin of SARS-CoV-2. Viruses. 2020 Oct 22;12(11). pii: E1203. doi: 10.3390/v12111203. PubMed PMID: 33105685.
0
Elrashdy F, Tambuwala MM, Hassan SS, Adadi P, Seyran M, El-Aziz TMA, Rezaei N, Lal A, Aljabali AAA, Kandimalla R, Bazan NG, Azad GK, Sherchan SP, Choudhury PP, Serrano-Aroca Á, Takayama K, Chauhan G, Pizzol D, Barh D, Panda PK, Mishra YK, Palù G, Lundstrom K, Redwan EM, Uversky VN. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. 2021 Sep 8:102941. doi: 10.1016/j.autrev.2021.102941. [Epub ahead of print] Review. PubMed PMID: 34508917.
7.767
Redwan EM, Alghamdi MF, El-Aziz TMA, Adadi P, Aljabali AAA, Attrish D, Azad GK, Baetas-da-Cruz W, Barh D, Bazan NG, Brufsky AM, Chauhan G, Hassan SKS, Kandimalla R, Lal A, Lundstrom K, Mishra YK, Choudhury PP, Palù G, Panda PK, Pizzol D, Rezaei N, Serrano-Aroca Á, Sherchan SP, Seyran M, Takayama K, Tambuwala MM, Uhal BD, Uversky VN. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19. Autoimmun Rev. 2021 Jul 15:102909. doi: 10.1016/j.autrev.2021.102909. [Epub ahead of print] PubMed PMID: 34274539.
7.767
Hassan SS, Lundstrom K, Barh D, Silva RJS, Andrade BS, Azevedo V, Choudhury PP, Palu G, Uhal BD, Kandimalla R, Seyran M, Lal A, Sherchan SP, Azad GK, Aljabali AAA, Brufsky AM, Serrano-Aroca Á, Adadi P, El-Aziz TMA, Redwan EM, Takayama K, Rezaei N, Tambuwala M, Uversky VN. Implications derived from S-protein variants of SARS-CoV-2 from six continents. Int J Biol Macromol. 2021 Sep 24. pii: S0141-8130(21)02005-5. doi: 10.1016/j.ijbiomac.2021.09.080. [Epub ahead of print] PubMed PMID: 34571123.
5.162
Zarandi PK, Zinatizadeh MR, Zinatizadeh M, Yousefi MH, Rezaei N. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments. Biomed Pharmacother. 2021 Feb 2;137:111352. doi: 10.1016/j.biopha.2021.111352. [Epub ahead of print] Review. PubMed PMID: 33550050.
4.545
Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev Med Virol. 2021 Mar 16:e2189. doi: 10.1002/rmv.2234. [Epub ahead of print] PubMed PMID: 33724604.
4.221
Seyran M, Hassan SS, Uversky VN, Pal Choudhury P, Uhal BD, Lundstrom K, Attrish D, Rezaei N, Aljabali AAA, Ghosh S, Pizzol D, Adadi P, El-Aziz TMA, Kandimalla R, Tambuwala MM, Lal A, Azad GK, Sherchan SP, Baetas-da-Cruz W, Palù G, Brufsky AM. Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks. Biomolecules. 2021 Mar 9;11(3). pii: 398. doi: 10.3390/biom11030398. PubMed PMID: 33803118.
4.082
Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, Sherchan SP, Azad GK, Rezaei N, Serrano-Aroca Á, Bazan NG, Hassan SS, Panda PK, Pal Choudhury P, Pizzol D, Kandimalla R, Baetas-da-Cruz W, Mishra YK, Palu G, Brufsky AM, Tambuwala MM, Uversky VN. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Biomolecules. 2021 Jul 13;11(7). pii: 1020. doi: 10.3390/biom11071020. PubMed PMID: 34356644.
4.082
Ahmadi M, Pashangzadeh S, Mousavi P, Saffarzadeh N, Amin Habibi M, Hajiesmaeili F, Rezaei N. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol. 2021 Mar 22;95:107568. doi: 10.1016/j.intimp.2021.107568. [Epub ahead of print] PubMed PMID: 33765612.
3.943
Salehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis. J Affect Disord. 2021 Jan 2;282:527-538. doi: 10.1016/j.jad.2020.12.188. [Epub ahead of print] Review. PubMed PMID: 33433382.
3.892
Sazgarnejad S, Yazdanpanah N, Rezaei N. Anti-inflammatory Effects of GLP-1 in Patients with COVID-19. Expert Rev Anti Infect Ther. 2021 Aug 4. doi: 10.1080/14787210.2021.1964955. [Epub ahead of print] PubMed PMID: 34348067.
3.767
Hassan SS, Aljabali AAA, Panda PK, Ghosh S, Attrish D, Choudhury PP, Seyran M, Pizzol D, Adadi P, Abd El-Aziz TM, Soares A, Kandimalla R, Lundstrom K, Lal A, Azad GK, Uversky VN, Sherchan SP, Baetas-da-Cruz W, Uhal BD, Rezaei N, Chauhan G, Barh D, Redwan EM, Dayhoff GW 2nd, Bazan NG, Serrano-Aroca Á, El-Demerdash A, Mishra YK, Palu G, Takayama K, Brufsky AM, Tambuwala MM. A unique view of SARS-COV-2 through the lens of ORF8 protein. Comput Biol Med. 2021 Apr 15;133:104380. doi: 10.1016/j.compbiomed.2021.104380. [Epub ahead of print] PubMed PMID: 33872970.
3.434
Rezaei N. COVID-19 and Medical Biotechnology. Avicenna J Med Biotechnol. 2020 Jul-Sep;12(3):139. PubMed PMID: 32695275; PubMed Central PMCID: PMC7368117.
3.388
Zamani R, Pouremamali R, Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci. 2021 Sep 17. doi: 10.1515/revneuro-2021-0082. [Epub ahead of print] PubMed PMID: 34536341.
3.358
Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci. 2021 Jun 4. doi: 10.1515/revneuro-2020-0154. [Epub ahead of print] Review. PubMed PMID: 34087964.
3.358
Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk. Rev Neurosci. 2020 Dec 23. doi: 10.1515/revneuro-2020-0066. [Epub ahead of print] PubMed PMID: 33580645.
3.358
Saleki K, Yaribash S, Banazadeh M, Hajihosseinlou E, Gouravani M, Saghazadeh A, Rezaei N. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies. Eur J Pharmacol. 2021 Jun 11:174248. doi: 10.1016/j.ejphar.2021.174248. [Epub ahead of print] Review. PubMed PMID: 34126092.
3.263
Pourriyahi H, Saghazadeh A, Rezaei N. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. J Neuroimmunol. 2021 Apr 16;356:577578. doi: 10.1016/j.jneuroim.2021.577578. [Epub ahead of print] Review. PubMed PMID: 33933818.
3.125
Noori M, Nejadghaderi SA, Rezaei N. "Original Antigenic Sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants. Infect Control Hosp Epidemiol. 2021 May 3:1-6. doi: 10.1017/ice.2021.199. [Epub ahead of print] PubMed PMID: 33938416.
2.938
Nowroozi A, Rezaei N. SARS-CoV-2 delta variant of concern breakthrough infections: Are vaccines failing us? Infect Control Hosp Epidemiol. 2021 Aug 6:1-4. doi: 10.1017/ice.2021.363. [Epub ahead of print] PubMed PMID: 34353385.
2.938
Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Deliv Transl Res. 2021 Sep 20. doi: 10.1007/s13346-021-01067-5. [Epub ahead of print] Review. PubMed PMID: 34542840.
2.664
Tantuoyir MM, Rezaei N. Serological Tests for COVID-19: Potential Opportunities. Cell Biol Int. 2021 Aug 10. doi: 10.1002/cbin.11686. [Epub ahead of print] PubMed PMID: 34374484.
2.571
Sargazi S, Sheervalilou R, Rokni M, Shirvaliloo M, Shahraki O, Rezaei N. The role of autophagy in controlling of SARS-CoV-2 infection: An overview with virophagy-mediated of molecular drug targets. Cell Biol Int. 2021 Apr 5. doi: 10.1002/cbin.11609. [Epub ahead of print] Review. PubMed PMID: 33818861.
2.571
Hanaei S, Mohebi F, Moradi-Lakeh M, Jabbari P, Mehta SK, Kryvenko LS, Luongo L, Dupré L, Rezaei N. The Epidemiologic Aspects of COVID-19 Outbreak: Spreading Beyond Expectations. Adv Exp Med Biol. 2021;1318:61-79. doi: 10.1007/978-3-030-63761-3_4. PubMed PMID: 33973172.
2.45
Moallemian Isfahani M, Emam-Djomeh Z, Rao IM, Rezaei N. Nutrition and Immunity in COVID-19. Adv Exp Med Biol. 2021;1318:485-497. doi: 10.1007/978-3-030-63761-3_28. PubMed PMID: 33973196.
2.45
Moradian N, Moallemian M, Delavari F, Sedikides C, Camargo CA Jr, Torres PJ, Sorooshian A, Mehdiabadi SP, Nieto JJ, Bordas S, Ahmadieh H, Abdollahi M, Hamblin MR, Sellke FW, Cuzick J, Biykem B, Schreiber M, Eshrati B, Perry G, Montazeri A, Saboury AA, Kelishadi R, Sahebkar A, Moosavi-Movahed AA, Vatandoost H, Gorji-Bandpy M, Mobasher B, Rezaei N. Interdisciplinary Approaches to COVID-19. Adv Exp Med Biol. 2021;1318:923-936. doi: 10.1007/978-3-030-63761-3_52. PubMed PMID: 33973220.
2.45
Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Coronavirus: Pure Infectious Disease or Genetic Predisposition. Adv Exp Med Biol. 2021;1318:91-107. doi: 10.1007/978-3-030-63761-3_6. PubMed PMID: 33973174.
2.45
Rezaei N, Ashkevarian S, Fathi MK, Hanaei S, Kolahchi Z, Ladi Seyedian SS, Rayzan E, Sarzaeim M, Vahed A, Mohamed K, Momtazmanesh S, Moradian N, Pirkoohi ZR, Sameeifar N, Yousefpour M, Sargoli S, Adiban S, Vahed A, Yazdanpanah N, Ziaei H, Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. Adv Exp Med Biol. 2021;1318:1-22. doi: 10.1007/978-3-030-63761-3_1. PubMed PMID: 33973169.
2.45
Eskian M, Rezaei N. Clinical Manifestations of COVID-19. Adv Exp Med Biol. 2021;1318:179-196. doi: 10.1007/978-3-030-63761-3_11. PubMed PMID: 33973179.
2.45
Kolahchi Z, De Domenico M, Uddin LQ, Cauda V, Grossmann I, Lacasa L, Grancini G, Mahmoudi M, Rezaei N. COVID-19 and Its Global Economic Impact. Adv Exp Med Biol. 2021;1318:825-837. doi: 10.1007/978-3-030-63761-3_46. PubMed PMID: 33973214.
2.45
Mojtabavi H, Javidi N, Naviaux AF, Janne P, Gourdin M, Mohammadpour M, Saghazadeh A, Rezaei N. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the COVID-19 Pandemic. Adv Exp Med Biol. 2021;1318:687-703. doi: 10.1007/978-3-030-63761-3_38. PubMed PMID: 33973206.
2.45
Delavari F, Varzaneh FN, Rezaei N. Neurologic Manifestations of COVID-19. Adv Exp Med Biol. 2021;1318:343-353. doi: 10.1007/978-3-030-63761-3_20. PubMed PMID: 33973188.
2.45
Rezaei N, Vahed A, Ziaei H, Bashari N, Afkham SA, Bahrami F, Bakhshi S, Ghanadan A, Ghanadan A, Hosseini N, Kafi P, Khalilianfard R, Mohammed K, Sargoli S, Tavasoli K, Zare M, Saghazadeh A. Health and Art (HEART): Integrating Science and Art to Fight COVID-19. Adv Exp Med Biol. 2021;1318:937-964. doi: 10.1007/978-3-030-63761-3_53. PubMed PMID: 33973221.
2.45
Moossavi S, Fehr K, Maleki H, Seyedpour S, Keshavarz-Fathi M, Tabasi F, Heravi M, Sharifian R, Shafiei G, Badihian N, Kelishadi R, Nematollahi S, Almasi M, Popescu S, Keshavarz-Fathi M, Rezaei N. Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions. Adv Exp Med Biol. 2021;1318:575-604. doi: 10.1007/978-3-030-63761-3_32. PubMed PMID: 33973200.
2.45
Mirbeyk M, Saghazadeh A, Rezaei N. Geriatrics and COVID-19. Adv Exp Med Biol. 2021;1318:209-222. doi: 10.1007/978-3-030-63761-3_13. PubMed PMID: 33973181.
2.45
Momtazmanesh S, Samieefar N, Uddin LQ, Ulrichs T, Kelishadi R, Roudenok V, Karakoc-Aydiner E, Salunke DB, Nouwen JL, Becerra JCA, Vieira DN, Goudouris E, Jamee M, Khafaie MA, Shamsizadeh M, Golabchi MR, Samimiat A, Doostkamel D, Afshar A, Tabari MAK, Lotfi M, Boroujeni RY, Rambod N, Stashchak A, Volokha A, Pavalkis D, Pereira A, Latiff AHA, Baylarov R, Amirheidari B, Ch MH, Condino-Neto A, Rezaei N. Socialization During the COVID-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing. Adv Exp Med Biol. 2021;1318:911-921. doi: 10.1007/978-3-030-63761-3_51. PubMed PMID: 33973219.
2.45
Quinaglia T, Shabani M, Rezaei N. COVID-19 in Patients with Hypertension. Adv Exp Med Biol. 2021;1318:243-261. doi: 10.1007/978-3-030-63761-3_15. PubMed PMID: 33973183.
2.45
Saghazadeh A, Rezaei N. How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment. Adv Exp Med Biol. 2021;1318:119-147. doi: 10.1007/978-3-030-63761-3_8. PubMed PMID: 33973176.
2.45
Gholami B, Gholami S, Loghman AH, Khodaei B, Seyedpour S, Seyedpour N, Saghazadeh A, Rezaei N. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease. Adv Exp Med Biol. 2021;1318:369-402. doi: 10.1007/978-3-030-63761-3_22. PubMed PMID: 33973190.
2.45
Mohamed K, Makuku R, Rodríguez-Román E, Hejleh APA, Joya M, Ivanovska M, Makka SA, Islam MS, Radwan N, Faten AB, Xiao C, Marquez L, Rezaei N. A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader. Adv Exp Med Biol. 2021;1318:891-910. doi: 10.1007/978-3-030-63761-3_50. PubMed PMID: 33973218.
2.45
Akbarpour M, Sharifi L, Safdarian AR, Farhangnia P, Borjkhani M, Rezaei N. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV. Adv Exp Med Biol. 2021;1318:149-167. doi: 10.1007/978-3-030-63761-3_9. PubMed PMID: 33973177.
2.45
Nowroozi A, Razi S, Sahu KK, Grizzi F, Arends J, Keshavarz-Fathi M, Rezaei N. COVID-19 in Patients with Cancer. Adv Exp Med Biol. 2021;1318:315-331. doi: 10.1007/978-3-030-63761-3_18. PubMed PMID: 33973186.
2.45
Fotouhi M, Samami E, Mohseni S, Nasrollahizadeh A, Haddadi M, Mirbeyk M, Saghazadeh A, Rezaei N. How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes? Adv Exp Med Biol. 2021;1318:293-313. doi: 10.1007/978-3-030-63761-3_17. PubMed PMID: 33973185.
2.45
Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol. 2021 Mar 16;21(1):116. doi: 10.1186/s12883-021-02152-5. PubMed PMID: 33726699.
2.356
Farmani AR, Mahdavinezhad F, Moslemi R, Mehrabi Z, Noori A, Kouhestani M, Noroozi Z, Ai J, Rezaei N. Anti-IgE monoclonal antibodies as potential treatment in COVID-19. Immunopharmacol Immunotoxicol. 2021 May 21:1-6. doi: 10.1080/08923973.2021.1925906. [Epub ahead of print] PubMed PMID: 34018464.
2.352
Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet. 2021 Apr 2. doi: 10.1007/s00404-021-06049-z. [Epub ahead of print] Review. PubMed PMID: 33797605.
2.283
Torabi-Rahvar M, Rezaei N. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm. Curr Pharm Des. 2020 Nov 24. doi: 10.2174/1381612826666201125102649. [Epub ahead of print] PubMed PMID: 33238863.
2.208
Keshavarz P, Yazdanpanah F, Azhdari S, Kavandi H, Nikeghbal P, Bazyar A, Rafiee F, Nejati SF, Sadabad FE, Rezaei N. Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome. J Med Virol. 2021 May 10. doi: 10.1002/jmv.27067. [Epub ahead of print] PubMed PMID: 33969513.
2.021
Yazdanpanah N, Rezaei N. Autoimmune Complications of COVID-19. J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292. [Epub ahead of print] Review. PubMed PMID: 34427929.
2.021
Sodeifian F, Nikfarjam M, Kian N, Mohamed K, Rezaei N. The Role of Type I Interferon in the Treatment of COVID-19. J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27317. [Epub ahead of print] Review. PubMed PMID: 34468995.
2.021
Ahanchian H, Moazzen N, Joghatayi SH, Saeidinia A, Khoshkhui M, Aelami MH, Rezaei N, Haghi NSM. Death due to COVID-19 in an Infant with Combined Immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2020 Oct 21. doi: 10.2174/1871530320666201021142313. [Epub ahead of print] PubMed PMID: 33087035.
1.973
3
Hessami A, Rezaei N. Cardiovascular diseases burden in COVID-19. Am J Emerg Med. 2021 Oct 2. pii: S0735-6757(21)00803-2. doi: 10.1016/j.ajem.2021.09.066. [Epub ahead of print] PubMed PMID: 34627644.
1.911
Razavi A, Hamblin MR, Rezaei N. COVID-19 in patients with cancer: Risks and precautions. Am J Emerg Med. 2021 Jan 28. pii: S0735-6757(21)00070-X. doi: 10.1016/j.ajem.2021.01.067. [Epub ahead of print] PubMed PMID: 33546958.
1.911
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med. 2020 Oct 16. pii: S0735-6757(20)30908-6. doi: 10.1016/j.ajem.2020.10.022. [Epub ahead of print] PubMed PMID: 33268238.
1.911
Mohamed K, Rezaei N. COVID-19 pandemic is not the time of trial and error. Am J Emerg Med. 2020 Sep 14. pii: S0735-6757(20)30814-7. doi: 10.1016/j.ajem.2020.09.020. [Epub ahead of print] PubMed PMID: 32988694.
1.911
2
Kafieh R, Arian R, Saeedizadeh N, Amini Z, Serej ND, Minaee S, Yadav SK, Vaezi A, Rezaei N, Haghjooy Javanmard S. COVID-19 in Iran: Forecasting Pandemic Using Deep Learning. Comput Math Methods Med. 2021 Feb 25;2021:6927985. doi: 10.1155/2021/6927985. eCollection 2021. PubMed PMID: 33680071; PubMed Central PMCID: PMC7907749.
1.77
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N. COVID-19 and picotechnology: Potential opportunities. Med Hypotheses. 2020 Jun 1;144:109917. doi: 10.1016/j.mehy.2020.109917. [Epub ahead of print] PubMed PMID: 32505072.
1.375
4
Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? Int J Health Serv. 2021 Mar 9:20731421993940. doi: 10.1177/0020731421993940. [Epub ahead of print] PubMed PMID: 33686893.
1.281
Samieefar N, Yari Boroujeni R, Jamee M, Lotfi M, Golabchi MR, Afshar A, Miri H, Khazeei Tabari MA, Darzi P, Abdullatif Khafaie M, Amirheidari B, Tamadon A, Rambod Rad N, Samimi N, Farjam M, Shiravi F, Farshidi N, Hedayati Ch M, Doostkamel D, Alikhani R, Razmkhah M, Abdollahifard S, Nasiri Kalmarzi R, Kelishadi R, Khazaei H, Aghamohammadi A, Jafari Mousavi FS, Shamsizadeh M, Khojasteh A, Rezaei N. Country Quarantine during COVID-19: Critical or Not? Disaster Med Public Health Prep. 2020 Oct 13:1-6. doi: 10.1017/dmp.2020.384. [Epub ahead of print] PubMed PMID: 33046176.
0.977
4
Hanaei S, Takian A, Majdzadeh R, Maboloc CR, Grossmann I, Gomes O, Milosevic M, Gupta M, Shamshirsaz AA, Harbi A, Burhan AM, Uddin LQ, Kulasinghe A, Lam CM, Ramakrishna S, Alavi A, Nouwen JL, Dorigo T, Schreiber M, Abraham A, Shelkovaya N, Krysztofiak W, Ebrahimi Warkiani M, Sellke F, Ogino S, Barba FJ, Brand S, Vasconcelos C, Salunke DB, Rezaei N. Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic. Disaster Med Public Health Prep. 2020 Oct 26:1-17. doi: 10.1017/dmp.2020.406. [Epub ahead of print] PubMed PMID: 33100253.
0.977
4
Mohammadi T, Nasab MG, Mohebalizadeh M, Kheirandish A, Saghazadeh A, Rezaei N. Dynamic Antibody Response: a Biomarker for COVID-19. Clin Lab. 2021 Apr 1;67(4). doi: 10.7754/Clin.Lab.2020.200848. PubMed PMID: 33865266.
0.94
Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep. 2021 Jan 5;9(3):1279-1282. doi: 10.1002/ccr3.3748. eCollection 2021 Mar. PubMed PMID: 33768826; PubMed Central PMCID: PMC7981657.
Shakerian N, Mofateh R, Saghazadeh A, Rezaei N, Rezaei N. Potential Prophylactic and Therapeutic Effects of Respiratory Physiotherapy for COVID-19. Acta Biomed. 2020 Nov 10;92(1):e2021020. doi: 10.23750/abm.v92i1.10289. PubMed PMID: 33682807.
Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Mater. 2021 Mar 10:1-20. doi: 10.1007/s42247-021-00192-8. [Epub ahead of print] Review. PubMed PMID: 33718777; PubMed Central PMCID: PMC7944718.
Peymani P, Dehesh T, Aligolighasemabadi F, Sadeghdoust M, Kotfis K, Ahmadi M, Mehrbod P, Iranpour P, Dastghaib S, Nasimian A, Ravandi A, Kidane B, Ahmed N, Sharma P, Shojaei S, Bagheri Lankarani K, Madej A, Rezaei N, Madrakian T, Los MJ, Labouta HI, Mokarram P, Ghavami S. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun. 2021;6(1):3. doi: 10.1186/s41231-021-00082-5. Epub 2021 Jan 25. PubMed PMID: 33521322; PubMed Central PMCID: PMC7829327.
Torabi S, Bahreini F, Rezaei N. The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury. Acta Biomed. 2020 Nov 10;91(4):e2020142. doi: 10.23750/abm.v91i4.10159. PubMed PMID: 33525252.
Sarzaeim M, Rezaei N. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19. SN Compr Clin Med. 2020 Oct 6:1-6. doi: 10.1007/s42399-020-00558-9. [Epub ahead of print] Review. PubMed PMID: 33043252; PubMed Central PMCID: PMC7538055.
Pourahmad R, Moazzami B, Rezaei N. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19. SN Compr Clin Med. 2020 Jul 31:1-5. doi: 10.1007/s42399-020-00438-2. [Epub ahead of print] Review. PubMed PMID: 32838178; PubMed Central PMCID: PMC7392618.
Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep. 2020 Aug 24;14(1):134. doi: 10.1186/s13256-020-02461-2. PubMed PMID: 32838801.
Sadeghmousavi S, Rezaei N. COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment. SN Compr Clin Med. 2020 Sep 3:1-6. doi: 10.1007/s42399-020-00504-9. [Epub ahead of print] Review. PubMed PMID: 32895640; PubMed Central PMCID: PMC7467844.
Mohamed K, Rezaei N, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, A Makka S, Joya M, Makuku R, Md Shahidul Islam, Nesrine Radwan, Laila Rahmah, Goda R, Sunny O Abarikwu, Mujtaba Shaw, Zoghi S, Irtsyan S, Ling I, Orsolya Cseprekal, Attig-Bahar F, Hazar Sayar E, Soloukey C, Giulia Grancini. International Efforts to Save Healthcare Personnel during COVID-19. Acta Biomed. 2020 Sep 7;91(3):e2020044. doi: 10.23750/abm.v91i3.9891. PubMed PMID: 32921737.
Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020 Sep 7;91(3):e2020018. doi: 10.23750/abm.v91i3.9718. PubMed PMID: 32921715.
Sodeifian F, Mushtaq S, Rezaei N. [Cutaneous Manifestation of COVID-19: What have we learned an year into the pandemic?]. Actas Dermosifiliogr. 2021 Sep 22. doi: 10.1016/j.ad.2021.08.005. [Epub ahead of print] Review. Spanish. PubMed PMID: 34580541; PubMed Central PMCID: PMC8457627.
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Cognitive Biases Affecting the Maintenance of COVID-19 Pandemic. Acta Biomed. 2021 May 12;92(2):e2021102. doi: 10.23750/abm.v92i2.11073. PubMed PMID: 33988147.
Zibadi S, Samieefar N, Sodeifian F, Mosavari N, Rezaei N. COVID-19 Vaccination: What Challenges Are We Going to Face. Acta Biomed. 2021 Sep 2;92(4):e2021379. doi: 10.23750/abm.v92i4.11759. PubMed PMID: 34487064.
Kolahchi Z, Sohrabi H, Ekrami Nasab S, Jelodari Mamaghani H, Keyfari Alamdari M, Rezaei N. Potential therapeutic approach of intravenous immunoglobulin against COVID-19. Allergy Asthma Clin Immunol. 2021 Oct 9;17(1):105. doi: 10.1186/s13223-021-00609-3. Review. PubMed PMID: 34627384.

Data Sources

IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

Phones

+34 968885229
+34 968885239
+34 968885249